Relieve. Appease. Support.
“Whoever is spared personal pain must feel himself called to help in diminishing the pain of others.” – Albert Schweitzer
Around the world, millions of patients suffer from drug-resistant pain on a daily basis. For many of them, medical cannabis drugs offer the hope of getting a new lease of life.
In 2021, France initiated national trials that will lead to the marketing authorisation of these new treatments in 2023, as more than 20 European countries before.
It is in the context of this experiment that Arcanes Pharma is participating in the development of a French sector of medicinal products based on natural cannabinoids.
Firstly by setting up a research laboratory (1) which aims to evolve from 2024 into a pharmaceutical laboratory (2) and finally with the building of a growing facility (3) on French soil in 2025, which is environmentally responsible and of course compliant with GMP.
Head Pharmacist, PharmD
PhD Crop Science
Head of Quality, GMP
SEND US A MESSAGE
18 Avenue Ratti
+33 (0) 6 15 36 67 20